Specificity and sensibility of 9-Itens Wearing-off Questionnaire in Brazilian Parkinson disease patient sample

Specificity and sensibility of 9-Itens Wearing-off Questionnaire in Brazilian Parkinson disease patient sample

Objective (1) To evaluate whether the Nine Items Questionnaire (WOQ-9) for the detection of wearing-off (WO) in Parkinson Disease (PD), by means of its screening ability, is a helpful tool to assist neurologists in diagnosing WO; (2) To determine the sensitivity and the specificity of a free Brazili...

Full description

Bibliographic Details
Main Authors:	Jasper Guimarães Santos, Hsin Fen Chien, Egberto Reis Barbosa
Format:	Article
Language:	English
Published:	Academia Brasileira de Neurologia (ABNEURO) 2014-11-01
Series:	Arquivos de Neuro-Psiquiatria
Subjects:	doença de Parkinson levodopa wearing-off questionários
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X2014001100867&lng=en&tlng=en

Similar Items

Validating the Vietnamese version of wearing – Off 19 questionnaire for patients with Parkinson's disease
by: Uyen Le Ngoc Ha, et al.
Published: (2019-01-01)

Identification of wearing-off manifestations (reduction of levodopa effect) in Parkinson's disease using specific questionnaire and comparison of the results with routine ambulatory evaluations Identificação de manifestações de wearing-off (redução do efeito da levodopa) em pacientes com doença de Parkinson utilizando questionário específico e comparação dos resultados com avaliações ambulatoriais de rotina
by: Luciano Magalhães Melo, et al.
Published: (2010-08-01)

Management of OFF condition in Parkinson disease
by: Jessa Koch, PharmD, BCPP, APh
Published: (2023-12-01)

Philippine translation and validation of the Wearing-off Questionnaire-19
by: Katrina C. Remigio, et al.
Published: (2019-01-01)

How I treat Parkinson's disease
by: Egberto Reis Barbosa, et al.
Published: (2022-08-01)

Discinesias induzidas por levodopa em 176 pacientes com doença de Parkinson Levodopa-induced dyskinesias in 176 parkisonian patients
by: Maria Sheila G. Rocha, et al.
Published: (1995-12-01)

Tratamento da doença de Parkinson
by: Francisco Cardoso
Published: (1995-03-01)

Correlation Between Lacunae and the Wearing-off Phenomenon in Parkinson’s Disease
by: Zhang M, et al.
Published: (2022-01-01)

A Digital Architecture for the Real-Time Tracking of Wearing off Phenomenon in Parkinson’s Disease
by: Giovanni Mezzina, et al.
Published: (2022-12-01)

The Added Benefit of Opicapone When Used Early in Parkinson's Disease Patients With Levodopa-Induced Motor Fluctuations: A Post-hoc Analysis of BIPARK-I and -II
by: José-Francisco Rocha, et al.
Published: (2021-11-01)

Prosody and levodopa in Parkinsons disease
by: Luciana Lemos de Azevedo, et al.
Published: (2013-11-01)

Wearing-off Identification in Parkinson's Disease: The shapd-woq Study
by: Ying Wan, et al.
Published: (2020-03-01)

Predictors of levo-dopa induced dyskinesias in Parkinson's disease
by: R T Athulya, et al.
Published: (2020-01-01)

Sleep disturbances in drug naïve Parkinson′s disease (PD) patients and effect of levodopa on sleep
by: Teresa Ferreira, et al.
Published: (2014-01-01)

Novos agonistas dopaminérgicos
by: MATTOS JAMES PITÁGORAS DE, et al.
Published: (1999-01-01)

Quality of life scale in parkinson's disease PDQ-39 - (Brazilian Portuguese version) to assess patients with and without levodopa motor fluctuation Escala para qualidade de vida na doença de Parkinson - PDQ 39 (versão do Português falado no Brasil) como instrumento para avaliação de pacientes com e sem flutuação motora decorrente da levodopa
by: Renata Guzzo Souza, et al.
Published: (2007-09-01)

Doença de Parkinson: Revisão Clínica e Atualização
by: Verónica Cabreira, et al.
Published: (2019-10-01)

Working memory in Parkinson's disease patients: clinical features and response to levodopa Memória de trabalho em pacientes com doença de Parkinson: características clínicas e resposta a levodopa
by: Rogério Beato, et al.
Published: (2008-06-01)

Sensor Measurements Can Characterize Fluctuations and Wearing Off in Parkinson’s Disease and Guide Therapy to Improve Motor, Non-motor and Quality of Life Scores
by: Parisa Farzanehfar, et al.
Published: (2022-03-01)

Vascular parkinsonism: A review on management updates
by: Thilini B Udagedara, et al.
Published: (2019-01-01)

Investigation of <i>PRKN</i> Mutations in Levodopa-Induced Dyskinesia in Parkinson’s Disease Treatment
by: Ana Gabrielle Bispo, et al.
Published: (2023-08-01)

The Experience of OFF Periods in Parkinson’s Disease: Descriptions, Triggers, and Alleviating Factors
by: Sneha Mantri, et al.
Published: (2021-07-01)

Clinical Use of On-Demand Therapies for Patients with Parkinson’s Disease and OFF Periods
by: Rajesh Pahwa, et al.
Published: (2023-05-01)

Levodopa for treatment of parkinson’s disease
by: M. Petraru, et al.
Published: (2011-09-01)

Harbinger of storm: influence of Oliver Sacks on levodopa therapy in early 1970s
by: Bruno Lopes dos Santos-Lobato, et al.
Published: (2016-08-01)

Molecular Mechanisms and Therapeutic Strategies for Levodopa-Induced Dyskinesia in Parkinson’s Disease: A Perspective Through Preclinical and Clinical Evidence
by: Ritam Bandopadhyay, et al.
Published: (2022-04-01)

Dynamics of levodopa-therapy in patients with Parkinson’s disease afterunilateral pallidotomy
by: V.I. Tsymbaliuk, et al.
Published: (2018-12-01)

Effects of different levodopa doses on blood pressure in older patients with early and middle stages of Parkinson's disease
by: Dan Su, et al.
Published: (2023-07-01)

Mythology of Parkinson’s disease: from levodopa phobia to dopamine agonist phobia
by: O. S. Levin, et al.
Published: (2020-12-01)

Avaliação nutricional e o uso da levodopa com refeições proteicas em pacientes com doença de Parkinson do município de Macaé, Rio de Janeiro
by: Thaís Pereira de Souza do Carmo, et al.

Amantadine and the Risk of Dyskinesia in Patients with Early Parkinson’s Disease: An Open-Label, Pragmatic Trial
by: Aryun Kim, et al.
Published: (2018-05-01)

Serial macro-architectural alterations with levodopa in Parkinson′s disease: Polysomnography (PSG)-based analysis
by: Sanju P Joy, et al.
Published: (2015-01-01)

Effect of Acute Levodopa Up-Titration on Blood Pressure in Patients With Early Stage Parkinson’s Disease: Results of a Levodopa Challenge Test
by: Xiaoqin He, et al.
Published: (2022-01-01)

Investigation of the Association of Homocysteine and MTHFR Polymorphisms and Treatment Options in Parkinson’s Disease in Central Anatolian Region*
by: Ramazan Emre, et al.
Published: (2015-12-01)

Rhabdomyolysis Related to Dyskinesia in Parkinson’s Disease
by: Hesna Bektaş, et al.
Published: (2014-04-01)

Combined and Sequential Treatment with Deep Brain Stimulation and Continuous Intrajejunal Levodopa Infusion for Parkinson’s Disease
by: Daniël van Poppelen, et al.
Published: (2021-06-01)

Istradefylline to Treat Patients with Parkinson’s Disease Experiencing “Off” Episodes: A Comprehensive Review
by: Amnon A. Berger, et al.
Published: (2020-12-01)

Malignant Syndrome in a Patient with Parkinson's Disease
by: Nesrin Helvacı Yılmaz, et al.
Published: (2012-09-01)

Parkinson’s disease, dopaminergic drugs and the plant world
by: Peter Kempster, et al.
Published: (2022-09-01)

Bereitschaftspotential preceding eyelid blinks in Parkinson’s disease
by: Isabella Araújo Mota, et al.